AdipoSeeds Inc.
Creates platelets from fat and creates a new blood flow
Current transfusion platelets are 100% dependent on blood donation and can only be stored for a few days. In the future, while the number of patients receiving anti-cancer drugs will increase as the population ages, the amount of blood donations will decrease due to the declining population, and it is only a matter of time before a platelet deficiency occurs. AdipoSeeds aims to use the created platelets as a blood transfusion substitute and wound healing based on the unique technology of artificially creating platelets from Mesenchymal stem cells derived from subcutaneous adipos tissue. The effects have been confirmed in animal experiments, and preparations are underway to confirm the safety and effects in humans.
- Establishment Date
- July 2016
- Business
- Commercialization of products such as regenerative medicine using cells derived from adipose tissue
- CEO
- Representative Director Yumiko Matsubara
KII’s Perspective
It is an epoch-making manufacturing method that solves the donor-dependent platelet deficiency, and its medical application range is not limited to platelet replacement and tissue repair, but it will be used in many therapeutic fields in the future. I hope it will be done.
KII growth support
Start-up support, Financing assistance, Business alliance support, Business alliance support, Corporate function support, Recruitment support, Appointment of directors
